Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | ESR1 | P03372 | 1/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.55 |
| ▸ | S100A4 | P26447 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.47 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25914505 | 0.84 | APP (0.50) | APPALDH1A1ESR1ESR2S100A4 | |
| SCHEMBL9810842 | 0.79 | ALDH1A1 (0.58) | APPALDH1A1ESR1ESR2S100A4 | |
| SCHEMBL3024023 | 0.78 | APP (0.66) | APPALDH1A1ESR1ESR2MEN1 | |
| SCHEMBL6651899 | 0.78 | ESR1 (0.59) | APPALDH1A1ESR1ESR2S100A4 | |
| SCHEMBL19200191 | 0.78 | ESR1 (0.50) | APPALDH1A1ESR1ESR2S100A4 | |
| SCHEMBL585483 | 0.78 | POLB (0.57) | APPALDH1A1ESR1ESR2S100A4 | |
| SCHEMBL1686814 | 0.78 | ESR1 (0.50) | APPALDH1A1ESR1ESR2S100A4 | |
| SCHEMBL10053401 | 0.77 | ALDH1A1 (0.59) | APPALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL7519644 | 0.76 | ALDH1A1 (0.63) | ALDH1A1ESR1ESR2MEN1KMT2A | |
| SCHEMBL2616778 | 0.76 | APP (0.67) | APPALDH1A1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504556-A | Bisphenol phthaloyl Process for producing imine | 潍坊弘润石化科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-117567411-A | Polyimide dianhydride monomer capable of realizing bidirectional polymerization and synthesis method thereof | 仪征市海帆化工有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-117247367-A | Novel polyimide dianhydride monomer and synthesis method thereof | 邹从伟 | 2023-12-19 | — | — | CN | claimed |
| CN-108727277-B | Singlet oxygen highly selective aggregation-induced chemiluminescence probe and preparation method and application thereof | 陕西师范大学 | 2021-03-30 | — | — | CN | claimed |
| CN-103965094-B | The synthetic method of the N-methyl-4-bromo-phthalimide of amino-5- | 江苏道博化工有限公司 | 2016-07-06 | — | — | CN | claimed |
| EP-0411304-B1 | Acetylene bis-phthalic compounds and polyimides made therefrom | GEN ELECTRIC (US) | 1994-06-15 | — | — | EP | claimed |
| EP-0411304-A1 | Acetylene bis-phthalic compounds and polyimides made therefrom | GENERAL ELECTRIC COMPANY (US) | 1991-02-06 | — | — | EP | claimed |
| US-20260125378-A2 | Heterocyclic Compounds | BEONE MEDICINES I GMBH (CH) | 2026-05-07 | — | — | US | disclosed |
| EP-4720065-A1 | PRMT5 INHIBITORS AND USES THEREOF | Insilico Medicine IP Limited (HK) | 2026-04-08 | — | — | EP | disclosed |
| EP-4658650-A1 | HETEROCYCLIC COMPOUNDS | Beone Medicines I GmbH (CH) | 2025-12-10 | — | — | EP | disclosed |
| US-20250353846-A1 | Heterocyclic Compounds | BEONE MEDICINES I GMBH (CH) | 2025-11-20 | — | — | US | disclosed |
| WO-2025067457-A1 | HETEROCYCLIC FUSED RING COMPOUND, AND COMPOSITION AND USE THEREOF | 深圳市塔吉瑞生物医药有限公司 | 2025-04-03 | — | — | WO | disclosed |
| CN-119504556-A | Bisphenol phthaloyl Process for producing imine | 潍坊弘润石化科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| EP-1709022-A1 | SELECTIVE ESTROGEN RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2006-10-11 | — | — | EP | disclosed |
| WO-2005073205-A1 | SELECTIVE ESTROGEN RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2005-08-11 | — | — | WO | disclosed |
| US-6191307-B1 | Process for making benzoic acids | ALBEMARLE CORPORATION | 2001-02-20 | — | — | US | disclosed |
| EP-0763521-A2 | Method of recycling phase transfer catalyst for displacement reactions | GENERAL ELECTRIC COMPANY (US) | 1997-03-19 | — | — | EP | disclosed |
| EP-0411304-B1 | Acetylene bis-phthalic compounds and polyimides made therefrom | GEN ELECTRIC (US) | 1994-06-15 | — | — | EP | disclosed |
| EP-0411304-A1 | Acetylene bis-phthalic compounds and polyimides made therefrom | GENERAL ELECTRIC COMPANY (US) | 1991-02-06 | — | — | EP | disclosed |
| US-4973707-A | Acetylene bis-phthalic compounds and polyimides made therefrom | GENERAL ELECTRIC COMPANY (US) | 1990-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125378-A2 | Heterocyclic Compounds | NFATC1, CD4, MALT1 | APP 3736/4885ALDH1A1 2837/4885ESR1 1922/4885 |
| US-20250353846-A1 | Heterocyclic Compounds | NFATC1, CD4, ACIN1 | APP 3889/4885ALDH1A1 1006/4885ESR1 1935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.